NCT03362437View on ClinicalTrials.gov

Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

December 28, 2017

Study Completion Date

December 28, 2017

Conditions
Thrombosis
Interventions
DRUG

BMS-986177

Form A

DRUG

BMS-986177

Form B

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03362437 - Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants | Biotech Hunter | Biotech Hunter